This is a preview of subscription content, log in via an institution to check access.
Notes
PMDA = Pharmaceuticals and Medical Devices Agency
References
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Tolvaptan. Internet Document : [2 pages], 20 Mar 2018. Available from: URL: http://www.pmda.go.jp/files/000223416.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Anagliptin. Internet Document : [1 page], 20 Mar 2018. Available from: URL: http://www.pmda.go.jp/files/000223418.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Anagliptin, linagliptin, and teneligliptin hydrobromide hydrate/canagliflozin hydrate. Internet Document : [2 pages], 20 Mar 2018. Available from: URL: http://www.pmda.go.jp/files/000223420.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Selexipag and preparations containing clopidogrel sulfate. Internet Document : [3 pages], 20 Mar 2018. Available from: URL: http://www.pmda.go.jp/files/000223417.pdf
Rights and permissions
About this article
Cite this article
Recent package insert revisions recommended by PMDA. Reactions Weekly 1696, 3 (2018). https://doi.org/10.1007/s40278-018-44191-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44191-6